Biogen wins ruling in Tecfidera IP case; shares rise
March 21, 2017 at 12:26 PM EDT
NEW YORK, March 21 (Reuters) - Biogen Inc on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down.
